Organogenesis
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $115,177 | $130,234 | $109,976 | $99,651 |
Gross Profit | 88,381 | 96,629 | 77,619 | 67,781 |
EBITDA | 10,698 | -9,720 | 144 | 5,036 |
EBIT | 6,294 | -13,920 | -6,032 | -1,294 |
Net Income | 12,331 | -17,043 | -2,100 | -568 |
Net Change In Cash | 115,177 | 130,234 | 109,976 | 99,651 |
Free Cash Flow | 6,126 | 2,858 | -12,384 | 7,289 |
Cash | 94,340 | 90,477 | 89,346 | 104,338 |
Basic Shares | 133,926 | 132,573 | 131,861 | 131,857 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $433,140 | $450,893 | $468,059 | $338,298 |
Gross Profit | 326,659 | 345,874 | 353,860 | 250,979 |
EBITDA | 36,031 | 40,322 | 86,998 | 37,226 |
EBIT | 12,582 | 22,291 | 70,322 | 29,043 |
Net Income | 4,945 | 15,532 | 94,202 | 17,234 |
Net Change In Cash | 433,140 | 450,893 | 468,059 | 338,298 |
Cost of Revenue | -11,238 | 29,722 | 24,436 | |
Free Cash Flow | 6,553 | -9,039 | 30,758 | -14,344 |
Cash | 104,338 | 102,478 | 113,929 | 84,394 |
Basic Shares | 132,746 | 132,383 | 133,662 | 111,360 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.09 |
2024-06-30 | $0.04 |
2024-03-31 | -$0.02 |
2023-12-31 | -$0.004 |
